Honasa Consumer Calls Off Fluence Pharma Acquisition Citing Unmet Conditions
Honasa Consumer, parent company of Mamaearth, has called off its planned acquisition of a 58 percent stake in nutraceuticals firm Fluence Pharma due to unmet closing conditions under the share purchase agreement. The Rs 135 crore deal was announced in June but did not specify which conditions were unmet. Despite the cancellation, Honasa remains committed to expanding in the nutraceutical sector through organic and inorganic opportunities, aiming to leverage Fluence's clinical expertise alongside its own brand and digital strengths.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 37/100.
Outlets measured: moneycontrol, economictimes. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
economictimes broke this story on 25 Aug, 03:57 pm. Other outlets followed.